BFA
INFI

BlackRock Fund Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

BlackRock Fund Advisors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.22M Sell
1,644,813
-423,130
-20% -$553K ﹤0.01% 3150
2016
Q3 		$3.23M Buy
2,067,943
+107,454
+5% +$165K ﹤0.01% 3045
2016
Q2 		$2.61M Sell
1,960,489
-763,430
-28% -$3.57M ﹤0.01% 3123
2016
Q1 		$14.4M Sell
2,723,919
-22,418
-0.8% -$137K ﹤0.01% 2172
2015
Q4 		$21.6M Sell
2,746,337
-47,431
-2% -$408K 0.01% 1999
2015
Q3 		$23.6M Sell
2,793,768
-18,644
-0.7% -$172K 0.01% 1889
2015
Q2 		$30.8M Buy
2,812,412
+230,150
+9% +$2.95M 0.01% 1832
2015
Q1 		$36.1M Buy
2,582,262
+137,708
+6% +$2.11M 0.01% 1729
2014
Q4 		$41.3M Buy
2,444,554
+294,715
+14% +$4.29M 0.01% 1587
2014
Q3 		$28.9M Sell
2,149,839
-111,744
-5% -$1.33M 0.01% 1735
2014
Q2 		$28.8M Buy
2,261,583
+360,491
+19% +$3.76M 0.01% 1795
2014
Q1 		$22.6M Sell
1,901,092
-148,000
-7% -$1.99M 0.01% 1926
2013
Q4 		$28.3M Buy
2,049,092
+70,018
+4% +$989K 0.01% 1776
2013
Q3 		$34.5M Buy
1,979,074
+186,493
+10% +$3.57M 0.01% 1600
2013
Q2 		$29M Buy
+1,792,581
New +$55.5M 0.01% 1585

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Fund Advisors's INFI Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its Infinity Pharmaceuticals, Inc. (INFI) stake by 20% in Q4 2016, selling an estimated $553K and leaving 1,644,813 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #3150.

BlackRock Fund Advisors first reported a position in INFI in Q2 2013 and has held it in 15 quarters since. The position peaked at $41.3M in Q4 2014. 94 funds tracked by Wall St. Rank hold INFI as of Q4 2016.

  • BlackRock Fund Advisors held 1,644,813 shares of Infinity Pharmaceuticals, Inc. worth $2.22M as of Q4 2016.
  • BlackRock Fund Advisors sold 423,130 Infinity Pharmaceuticals, Inc. shares in Q4 2016, an estimated $553K.
  • Infinity Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3150 holding.
  • BlackRock Fund Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Infinity Pharmaceuticals, Inc. position peaked at $41.3M in Q4 2014.
  • 94 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.